Glyco-Immune Diagnostic Signatures and Therapeutic Targets of Mesothelioma
Technical Report,15 Jun 2010,14 Jun 2015
New York University School of Medicine New York United States
Pagination or Media Count:
The focus of this grant was to investigate immunoprofiles for serum antibodies to aberrant glycans in human and animal models of mesothelioma. This was accomplished using a one of a kind printed glycan array which is at NYU School of Medicine NYUSoM. It was hoped that these experiments will allow us to diagnose and prognosticate mesothelioma more accurately in the future. We were severely limited by our ability to start the human mesothelioma glycoprofiles as well as the animal profiles due to delivery and set up times for our one of a kind glycomics laboratory at NYUSoM. We summarize our findings in the final report.